Thank you to all of our amazing runners! We truly appreciate all your dedication and hard work to help us in the fight against ALS!
Claire Schulz Bergman Bennett Camarda
Thomas Davidson Anna Maria Farrell Joseph Hughes
Anne Maloney Andrea Lytle Peet Claudia Salmeron Carol Wilke Kelsey Wolf David Zlotnick
APPLICATIONS ARE NOW CLOSED FOR 2024
The ALS Therapy Development Institute (ALS TDI) is proud to announce our Official Charity Partnership with the 2024 TCS New York City Marathon. Team ALS TDI features runners from all over the globe with one universal mission, finding a cure for ALS. On Sunday, November 3rd, our runners will complete the 26.2 mile run around all five boroughs of NYC to raise awareness for ALS TDI. Your donations fuel our continuous efforts to advance promising drugs and help put a stop to this terrible disease. Please join in our fight to #EndALS.
Benefits of Running the 2024 TCS New York City
Marathon for Team ALS TDI
- Fundraising tips and assistance in the creation of a peer-to-peer web page for personal fundraising.
- Virtual 16-week training program provided by 6-Star Abbott World Marathon Majors Award recipient, Neil Gottlieb.
- Branded training and race apparel.
- Pre-race "carb load" dinner on Saturday evening before the race.
- "Cheer" zone along race course to keep runners motivated!
ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) is the world's foremost drug discovery lab focused solely on ALS. As a nonprofit biotech we operate without regard to profit or politics. Led by drug development experts and people with ALS, our Watertown, Massachusetts based lab is funded by a global network of supporters unified to end ALS. Our mission is to discover and develop effective treatments for ALS.
As the Drug Discovery Engine for ALS, ALS TDI works to invent and discovers drugs until everyone with ALS has effective treatments. Our goal is to advance a new drug to clinical trial every two years, and funds raised from the Marathon are vital to achieving this.
Learn more at www.als.net